Company Filing History:
Years Active: 2008
Title: Ulrike Siebers: Innovator in Genetic Research
Introduction
Ulrike Siebers is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of genetic research, particularly in the area of gene modulation. Her work has implications for understanding complex biological pathways and developing new therapeutic strategies.
Latest Patents
Ulrike Siebers holds 1 patent related to the identification and use of the DAF-2/IR responsive sod-3 promoter. This invention describes transgenic constructs containing the sod-3 reporter gene, which are useful for identifying genes or compounds that can modulate the DAF-2/IR-akt pathway. The patent also discloses conditions that can either increase or decrease reporter activity, demonstrating the presence of activators or inhibitors of the DAF-2/IR pathway.
Career Highlights
Ulrike Siebers is currently employed at Sanofi-Aventis Deutschland GmbH, where she continues her research and development efforts. Her work at this leading pharmaceutical company allows her to collaborate with other experts in the field and contribute to innovative solutions in healthcare.
Collaborations
Some of her notable coworkers include Edmund Hoppe and Heike Schauerte. Their collaborative efforts enhance the research environment and foster innovation within their projects.
Conclusion
Ulrike Siebers is a key figure in genetic research, with her patent work paving the way for advancements in understanding gene modulation. Her contributions are vital for future developments in therapeutic applications.